UHS logo

UNIVERSAL HEALTH SERVICES-B

UHSNYSE
πŸ† #844 by market capEarnings Oct 28 Β· PostUS Equity
$119.31β–² $1.52 (+1.27%)
Simulated price
πŸ””
Track UHS
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 1.3%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$10.74B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+9.7%
Slowing
πŸ“ŠGross Margin
90.7%
High
πŸ’΅FCF Margin
4.6%
Moderate
βš–οΈP/S Ratio
0.6x
Cheap
Otter Score
72
Fair
No chart data available for UHS.

Trading Snapshot

Day Range
$118.35 – $120.80
52-Week Range
$140.08 – $246.33
Volume
$1.85B
Avg Volume
$2.16B
Shares Outstanding
60.5M
Next Earnings
Nov 22, 2026

Fundamentals Snapshot

Annual Revenue
$17.36B
Last Q Revenue
$4.64B
P/E Ratio
7.2
P/S Ratio
0.6x
EPS (TTM)
$25.59
Dividend Yield
0.45%
Dilution (1yr)
βˆ’3.9%

Why Investors Own UHS

  • βœ“High-growth profile β€” revenue up -7.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 53% gross margin and 8% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

UHS logo

UNIVERSAL HEALTH SERVICES-B

UHS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$17.4Bβ–² +9.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
90.4%β–² +0.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$2.0Bβ–² +18.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$849Mβ–Ό βˆ’24.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
64.5Mβ–Ό βˆ’3.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$5.4Bβ–Ό βˆ’$540M YoY
StockOtter Β· stockotter.space

About UNIVERSAL HEALTH SERVICES-B

Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
72/100

Analyst Price Target

β“˜
Average Target
$145.17
β–² +21.7% Upside
High Target$176.63
Low Target$110.36
Based on 31 analysts

Latest News & Updates